invcase-1.jpg

1

The leading global player

in airways disease formulation and device development with proven capabilities and expertise in its strategic areas

Learn more about us
invcase-2.jpg

2

Value underpinned by existing marketed products

Learn more about our in-market products
invcase-6.jpg

3

Valuable expertise both in formulation and devices

endorsed by a number of high quality partners

Learn more about our capabilities
invcase-4.jpg

4

Refocused R&D strategy with progress already demonstrated

increases focus on lower risk, higher value assets that leverage proven capabilities and will enhance cash flows

Learn more about our pipeline
invcase-5.jpg

5

Substantial operational leverage

to deliver higher profitability and unlock growth potential

Learn more from our investors section
invcase-6.jpg

6

Appropriate capital structure allocation

Learn more in our recent financial reports